No Data
Shanghai MicroPort EP MedTech (SHSE:688351) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
2.824 million restricted shares of Wei Dian Sheng Li (688351.SH) will be listed for trading starting from September 2nd.
Micro-physiology (688351.SH) announced that the restricted shares to be listed for the first time are part of the company's initial public offering...
Half-year report for the year 2024.
Summary of Half-Year Report in 2024.
Micro-electrophysiology (688351.SH): The net income in the first half of the year was 17.0127 million yuan, a year-on-year increase of 689.30%.
Micro-electrophysiology (688351.SH) announced its semi-annual report for the first half of 2024, reporting operating revenue of 0.198 billion yuan, a year-on-year growth of 39.57%; net income attributable to shareholders of the listed company was 17.0127 million yuan, a year-on-year growth of 689.30%; net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 0.9217 million yuan, a YoY turnaround from loss to profit; basic earnings per share was 0.0362 yuan. Operating revenue increased by 39.57% compared to the same period last year, mainly due to the continuous expansion of the company's business scale and an increase in product sales volume.
Southwest Securities: How to view the investment opportunities and challenges of high-value consumables in the post-medicine group purchase era?
In the context of centralized procurement, most areas in the high-value consumables field are currently highly competitive and have limited growth potential. Therefore, the tracks with low penetration rates and low localization rates have long-term growth potential.
Shanghai MicroPort EP MedTech Co., Ltd.'s (SHSE:688351) Price In Tune With RevenuesNo Data
